Variant report

Variant	rs73005302
Chromosome Location	chr2:149312512-149312513
allele	A/G
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Distal block	Cell Line	Cell type	Cell Stage
1	chr2:149308756..149311819-chr2:149312294..149315148,3	K562	blood:

Extended variants
information (count: 37 )
Associated
traits (count: 0)

rSNPs within LD-proxies of this variant (count:29)

rs_ID	r²[population]
rs12615627	0.85[EUR][1000 genomes]
rs12620020	1.00[AFR][1000 genomes];1.00[AMR][1000 genomes];1.00[EUR][1000 genomes];1.00[ASN][1000 genomes]
rs12622366	0.82[AMR][1000 genomes];0.96[EUR][1000 genomes];0.89[ASN][1000 genomes]
rs12691800	0.98[EUR][1000 genomes];0.97[ASN][1000 genomes]
rs12691802	0.94[EUR][1000 genomes];0.90[ASN][1000 genomes]
rs13014625	0.96[EUR][1000 genomes];0.90[ASN][1000 genomes]
rs13014829	0.96[EUR][1000 genomes];0.90[ASN][1000 genomes]
rs1550858	0.84[AFR][1000 genomes];0.89[AMR][1000 genomes];0.98[EUR][1000 genomes]
rs1868396	0.98[EUR][1000 genomes];0.97[ASN][1000 genomes]
rs1868397	0.98[EUR][1000 genomes];0.97[ASN][1000 genomes]
rs1975596	0.98[EUR][1000 genomes];0.96[ASN][1000 genomes]
rs4609986	0.88[AFR][1000 genomes];0.93[AMR][1000 genomes];0.98[EUR][1000 genomes];0.99[ASN][1000 genomes]
rs4972284	0.98[EUR][1000 genomes];0.98[ASN][1000 genomes]
rs4972376	0.96[EUR][1000 genomes];0.97[ASN][1000 genomes]
rs4972379	0.98[EUR][1000 genomes];0.97[ASN][1000 genomes]
rs4972382	0.98[EUR][1000 genomes];0.96[ASN][1000 genomes]
rs4972385	0.94[EUR][1000 genomes];0.88[ASN][1000 genomes]
rs55933306	0.85[EUR][1000 genomes]
rs56797270	1.00[EUR][1000 genomes]
rs57835656	0.86[AFR][1000 genomes];0.86[AMR][1000 genomes];1.00[EUR][1000 genomes];0.98[ASN][1000 genomes]
rs6708007	0.96[EUR][1000 genomes];0.90[ASN][1000 genomes]
rs73005293	0.85[AFR][1000 genomes];0.89[AMR][1000 genomes];1.00[EUR][1000 genomes]
rs73005300	0.90[AMR][1000 genomes];1.00[EUR][1000 genomes];1.00[ASN][1000 genomes]
rs73007306	0.90[AMR][1000 genomes];1.00[EUR][1000 genomes];0.99[ASN][1000 genomes]
rs73007314	0.99[AFR][1000 genomes];1.00[AMR][1000 genomes];1.00[EUR][1000 genomes];1.00[ASN][1000 genomes]
rs73007341	0.85[AFR][1000 genomes];0.82[AMR][1000 genomes];1.00[EUR][1000 genomes];0.98[ASN][1000 genomes]
rs73016733	0.91[EUR][1000 genomes];0.90[ASN][1000 genomes]
rs7579702	0.94[EUR][1000 genomes];0.90[ASN][1000 genomes]
rs9287418	0.98[EUR][1000 genomes];0.96[ASN][1000 genomes]

Variant overlapped rSNPs/rCNVs (count:8 , 50 per page) page: 1

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	nsv1012275	chr2:149031668-149316793	Enhancers Strong transcription Flanking Active TSS Weak transcription Active TSS ZNF genes & repeats Genic enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region lncRNA	5 gene(s)	inside rSNPs	diseases
2	esv2751831	chr2:149151358-150105603	Weak transcription Flanking Bivalent TSS/Enh Strong transcription Enhancers Active TSS Bivalent/Poised TSS Flanking Active TSS Genic enhancers Bivalent Enhancer ZNF genes & repeats Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	36 gene(s)	inside rSNPs	diseases
3	nsv1000101	chr2:149165813-149361220	Enhancers Strong transcription Genic enhancers Weak transcription Flanking Active TSS Active TSS Bivalent Enhancer ZNF genes & repeats Bivalent/Poised TSS Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA	5 gene(s)	inside rSNPs	diseases
4	nsv868861	chr2:149198443-149434604	Enhancers Weak transcription Flanking Active TSS Active TSS Bivalent Enhancer Strong transcription Genic enhancers Bivalent/Poised TSS Flanking Bivalent TSS/Enh ZNF genes & repeats Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA	11 gene(s)	inside rSNPs	diseases
5	nsv917109	chr2:149198443-149948302	ZNF genes & repeats Weak transcription Flanking Active TSS Enhancers Genic enhancers Flanking Bivalent TSS/Enh Strong transcription Bivalent/Poised TSS Bivalent Enhancer Active TSS Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	36 gene(s)	inside rSNPs	diseases
6	nsv1004663	chr2:149214090-149373061	Enhancers Active TSS Flanking Active TSS Strong transcription ZNF genes & repeats Weak transcription Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh Genic enhancers Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA	5 gene(s)	inside rSNPs	diseases
7	esv2762913	chr2:149249683-149345487	Weak transcription Enhancers Active TSS Flanking Active TSS Strong transcription Bivalent Enhancer Genic enhancers Bivalent/Poised TSS ZNF genes & repeats Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3'	Chromatin interactive region lncRNA	4 gene(s)	inside rSNPs	diseases
8	nsv527539	chr2:149283070-149330251	Enhancers Flanking Active TSS Weak transcription Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Bivalent/Poised TSS ZNF genes & repeats	Chromatin interactive region	2 gene(s)	inside rSNPs	diseases

No data

Chromatin state (count:25 , 50 per page) page: 1

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr2:149310400-149313000	Enhancers	H9 Derived Neuron Cultured Cells	ES cell derived
2	chr2:149310800-149313200	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
3	chr2:149311000-149313000	Enhancers	H9 Cell Line	embryonic stem cell
4	chr2:149311200-149312800	Enhancers	Primary hematopoietic stem cells short term culture	blood
5	chr2:149311400-149312800	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Male	--
6	chr2:149311400-149313000	Enhancers	Primary T helper naive cells fromperipheralblood	blood
7	chr2:149311400-149313000	Enhancers	Primary T helper cells fromperipheralblood	blood
8	chr2:149311400-149313200	Enhancers	ES-WA7 Cell Line	embryonic stem cell
9	chr2:149311400-149313600	Enhancers	iPS-15b Cell Line	embryonic stem cell
10	chr2:149311600-149312600	Enhancers	iPS DF 6.9 Cell Line	embryonic stem cell
11	chr2:149311600-149312600	Enhancers	Primary T helper cells PMA-I stimulated	--
12	chr2:149311600-149312800	Enhancers	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
13	chr2:149311600-149313400	Enhancers	H1 Cell Line	embryonic stem cell
14	chr2:149311600-149314000	Enhancers	iPS-18 Cell Line	embryonic stem cell
15	chr2:149311600-149314000	Weak transcription	Fetal Lung	lung
16	chr2:149311800-149312800	Flanking Active TSS	ES-I3 Cell Line	embryonic stem cell
17	chr2:149311800-149313000	Flanking Active TSS	iPS-20b Cell Line	embryonic stem cell
18	chr2:149312000-149312800	Enhancers	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
19	chr2:149312000-149315800	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
20	chr2:149312200-149312600	Weak transcription	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
21	chr2:149312400-149312600	Enhancers	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
22	chr2:149312400-149312600	Flanking Active TSS	HUES48 Cell Line	embryonic stem cell
23	chr2:149312400-149312600	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Female	--
24	chr2:149312400-149312800	Enhancers	HUES64 Cell Line	embryonic stem cell
25	chr2:149312400-149313000	Flanking Active TSS	HUES6 Cell Line	embryonic stem cell

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links